Primary progressive Multiple sclerosis

BioMS Medical completes patient recruitment in phase III clinical ...
RTT News - Williamsville,NY,USA
(MS.TO: News, Chart, Quote ) announced that it has completed patient recruitment in its phase III clinical trial of MBP8298 for the treatment of secondary ...
See all stories on this topic

 

BioMS Medical completes patient recruitment in phase III US ...
FOXBusiness - USA
"Since initiating this trial in June 2007 we have been delighted by the enthusiasm of the patients and clinical groups participating across the US" MBP8298 ...
See all stories on this topic

 

MS registry seeks participants
The Oregonian

Wed, 30 Jul 2008 0:03 AM PDT

Oregon is a multiple sclerosis hot spot: fact or myth? Or something in between? Dr. Stanley Cohan, medical director of the Providence Multiple Sclerosis Center and founder of the Pacific Northwest Multiple Sclerosis Registry, hopes to find the answer.

 

She's not just 'The Girl With MS'
The Oregonian

Wed, 30 Jul 2008 0:04 AM PDT

Kim Feller kept her multiple sclerosis a secret for years. Even from close friends. She told only her brother -- "my best friend" -- and her mother.
. 

 

National MS Society, Michigan Chapter & Organic Digital Announce Launch Of New Da Vinci Awards(R) Web Site
Medical News Today

Wed, 30 Jul 2008 4:11 AM PDT

Annually for the last seven years, the National Multiple Sclerosis Society, Michigan Chapter has hosted the da Vinci Awards® in recognition of outstanding achievements in technologies, designs, and disciplines that enhance personal mobility. This week the Society is pleased to announce the unveiling of a completely redesigned Web site dedicated to the da Vinci Awards - http://www.

 

 

Nutra Pharma Announces Completion Of Clinical Study In Adrenomyeloneuropathy (AMN)
Medical News Today

Wed, 30 Jul 2008 2:13 AM PDT

Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis, has announced today that its wholly-owned drug discovery subsidiary, ReceptoPharm, Inc.
Study reveals piece in the celiac puzzle

 

 

Baltimore Sun

Thu, 31 Jul 2008 0:44 AM PDT

Autoimmune disease trigger possibly found Maryland researchers have identified a key receptor in the intestine that can trigger celiac disease, and they hope their findings can be applied to other autoimmune disorders, such as Type 1 diabetes and multiple sclerosis.
Fasano's next step is to see if the receptor CXCR3 releases abnormal amounts of zonulin in patients with other autoimmune disorders, such as Type 1 diabetes and multiple sclerosis. The intestines may be a port of entry through which the instigators of these diseases may gain access to the body, he said.


Peptimmune Announces Grant Of United States Patent For PI-2301 Peptide Copolymer For Multiple Sclerosis
Medical News Today

Thu, 31 Jul 2008 3:12 AM PDT

Peptimmune, Inc. a privately held biotechnology company, announced today the grant of US Patent Number 7,381,790 (the '790 patent) which protects the composition of matter for its PI-2301 peptide copolymer for the treatment of autoimmune diseases.

 

 

 

Probiotics

Have fewer sick days!
Malaysia Star - Malaysia
Probiotics are the beneficial bacteria naturally found in the intestinal tract that keeps harmful bacteria at bay. Probiotics such as lactobacilli, ...
See all stories on this topic

 

 

 

Making Sense of Yogurt Choices
Food Consumer - Lisle,IL,USA
Here’sa quick tutorial: Probiotics. All yogurts provide probiotics, live microorganisms (bacteria) that confer a wide range of potential health benefits. ...
See all stories on this topic

 

 

---

 

Caregivers / Homecare News

House Panel Approves Legislation That Would Invalidate Mandatory Binding Arbitration Provisions Of Nursing Home Admission Contracts
The House Judiciary Committee on Wednesday by a 17-10 vote approved a bill (HR 6126) that would ban the use of mandatory arbitration clauses in nursing home contracts, CQ Today reports (Stern, CQ Today, 7/30).

---

 

 

Tysabri

Health Highlights: August 2, 2008
U.S. News & World Report - Washington,DC,USA
Two new instances of a dangerous brain infection have been reported among users of Tysabri, a multiple sclerosis drug that was reintroduced two years ago ...
See all stories on this topic

Scare sees Elan shares crash
Herald.ie - Dublin,Ireland
DRUGS giant Elan has lost over half its share value in early Dublin trading this morning after its popular Tysabri multiple sclerosis drug was linked to two ...
See all stories on this topic

Despite risks, many staying with Tysabri
Boston Globe - United States
Or Cavallo could try a powerful new drug, Tysabri, that carried a worrisome side effect - it was linked to a rare and potentially fatal brain disease that ...
See all stories on this topic

New PML Cases Mar Tysabri's Two-Year Anniversary in MS
BioWorld Online - Atlanta,GA,USA
During an investor call Friday morning, Biogen management reported that two Tysabri patients in Europe had confirmed cases of PML (progressive multifocal ...
See all stories on this topic

Tysabri users not properly monitored, says expert
Irish Times - Dublin,Ireland
PATIENTS WITH multiple sclerosis (MS) who are taking the drug Tysabri are not being properly monitored for serious side effects because of health service ...
See all stories on this topic

Biogen, Elan's Tysabri Is Likely to Lose Sales on Infections
Bloomberg - USA
s report about new potentially deadly infections linked to Tysabri will cause some physicians and patients to avoid the multiple- sclerosis therapy and ...
See all stories on this topic

Biggest daily decline for ISEQ since 1997
Irish Examiner - Cork,Ireland
Irish pharmaceutical giant Elan has said that its headline product — the multiple sclerosis (MS) drug, Tysabri — will not be taken off the market, ...
See all stories on this topic

Risks Run High For Biogen, Elan
Forbes - NY,USA
Currently, Aoki said, there are more than 31800 patients on Tysabri therapy, which is the most effective treatment for MS on the market. ...
See all stories on this topic

Safety Scares Hit Elan, Biogen And Schering
Forbes - NY,USA
The disorder, called progressive multifocal leukoencephalopathy (PML), led to Tysabri's withdrawal from the market in 2005. The drug was eventually allowed ...
See all stories on this topic

MARKET SNAPSHOT: US Stocks End Week Mixed On Economic Concerns
CNNMoney.com - USA
Elsewhere, Elan plunged 50% and Biogen Idec shares slid 28% after the companies said their multiple sclerosis drug Tysabri was linked to two new cases of a ...
See all stories on this topic

Broad-Based Weakness
Briefing.com - Burlingame,CA,USA
... plunged 28% after announcing that there have been two confirmed cases of a rare brain disease in patients taking its multiple sclerosis drug Tysabri.
See all stories on this topic

---

Power of the Mind

Change your mind and change your life! Your brain has more power than you know. How can you unleash it? The answers may transform the way you think, act and live!
Tonight, 9 pmET!
__________________________________________________
VIEWER'S CHOICE! Let us know who YOU want to see MOST on Larry King Live!

http://www.cnn.com/CNN/Programs/larry.king.live/
http://www.cnn.com/CNN/Programs/larry.king.live/

---

 

 

Questions/Answers
Inland Valley Daily Bulletin

Thu, 31 Jul 2008 10:01 PM PDT

Questions and answers on Daily Bulletin stories from readers like you. Montel Williams is 51, has six-pack abs, a new wife and multiple sclerosis. He's equally fine with all of it.



Brain Tweak Lets Sleep-deprived Flies Stay Sharp
Staying awake slows down our brains, scientists have long recognized. Mental performance is at its peak after sleep but inevitably trends downward throughout the day, and sleep deprivation only worsens these effects.

 

Multiple sclerosis stem cells

Beike Uses Research Forum to Showcase its Stem Cell Therapies
istockAnalyst.com - Salem,OR,USA
... for several rounds of stem cells injections, which it says can help cure diseases such as Alzheimer’s, atoxia, heart conditions, multiple sclerosis, ...
See all stories on this topic

Disability Affects Three Out of Every 10 U.S. Adults

HYATTSVILLE, Md. -- Nearly 30% of the noninstitutionalized adult U.S. population -- about 62 million people -- have some disability that affects daily activity. full story

http://www.medpagetoday.com/PublicHealthPolicy/PublicHealth/tb/10268

Yale Researchers Find New Trigger For Autoimmune Diseases
Yale University researchers have discovered a new way that autoimmune diseases like multiple sclerosis (MS) can be triggered, they reported Monday in the journal Proceedings of the National Academy of Sciences.

 

Genmab Shares Rise as Cancer Treatment Succeeds in New Test
Bloomberg - USA
The product, ofatumumab, met the goals of a study of 154 chronic lymphocytic leukemia patients whose disease hadn't responded to other medicines, ...
See all stories on this topic